Compare Adaptive Biotechnologies Corp (ADPT) vs Brookfield Infrastructure Partners LP (BIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Brookfield Infrastructure Partners LP — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Brookfield Infrastructure Partners LP trades at $39 (market cap $18.10B). The key difference: Brookfield Infrastructure Partners LP is far larger — about 4.5× Adaptive Biotechnologies Corp's market cap, and Brookfield Infrastructure Partners LP pays a 4.62% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | BIP | |
|---|---|---|
Market Cap | $4.04B | $18.10B |
Sector | Health | Industrials |
52-Week High | $25.45 | $42.62 |
52-Week Low | $12.30 | $29.81 |
Enterprise Value | $4.10B | $77.05B |
Dividend Yield | — | 4.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Brookfield Infrastructure Partners LP
Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →
